Huntsman (HUN) Financials

Huntsman logo
$9.02 -0.18 (-1.90%)
Closing price 03:59 PM Eastern
Extended Trading
$9.03 +0.01 (+0.17%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Huntsman

Annual Income Statements for Huntsman

This table shows Huntsman's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
93 326 636 674 562 1,034 1,045 460 101 -189 -284
Consolidated Net Income / (Loss)
126 357 741 987 598 1,066 1,104 523 153 -127 -227
Net Income / (Loss) Continuing Operations
428 365 511 689 429 289 1,055 511 35 -100 -218
Total Pre-Tax Income
488 474 531 734 391 331 1,246 697 99 -39 -192
Total Operating Income
717 663 729 827 469 432 731 672 84 -25 -131
Total Gross Profit
1,734 1,518 1,651 1,764 1,382 977 1,584 1,546 906 866 751
Total Revenue
8,139 7,518 6,845 7,604 6,797 5,421 7,670 8,023 6,111 6,036 5,683
Operating Revenue
8,139 7,518 6,845 7,604 6,797 5,421 7,670 8,023 6,111 6,036 5,683
Total Cost of Revenue
6,405 6,000 5,194 5,840 5,415 4,444 6,086 6,477 5,205 5,170 4,932
Operating Cost of Revenue
6,405 6,000 5,194 5,840 5,415 4,444 6,086 6,477 5,205 5,170 4,932
Total Operating Expenses
1,017 855 922 940 913 545 853 874 822 891 882
Selling, General & Admin Expense
791 772 759 789 786 670 739 711 689 671 670
Research & Development Expense
143 137 132 145 137 121 135 125 115 121 120
Other Operating Expenses / (Income)
- -101 -16 8.00 31 -287 -61 -48 0.00 60 -23
Impairment Charge
- - - - - - - - - 39 148
Other Special Charges / (Income)
- - - 3.00 - - - - 0.00 0.00 -33
Total Other Income / (Expense), net
-229 -189 -198 -90 -78 -101 515 25 15 -14 -61
Interest & Investment Income
-199 -198 -152 -122 -75 -132 513 5.00 18 -35 -75
Other Income / (Expense), net
1.00 12 8.00 32 20 31 29 20 -3.00 21 14
Income Tax Expense
60 109 20 45 -38 42 191 186 64 61 26
Net Income / (Loss) Discontinued Operations
-302 -8.00 230 -310 169 777 49 12 118 -27 -9.00
Net Income / (Loss) Attributable to Noncontrolling Interest
33 31 105 313 36 32 59 63 52 62 57
Basic Earnings per Share
$0.38 $1.38 $2.67 $1.42 $2.46 $4.69 $4.77 $2.29 $0.57 ($1.10) ($1.65)
Weighted Average Basic Shares Outstanding
242.80M 236.30M 238.40M 238.10M 228.90M 220.60M 219.20M 201M 177.40M 172.10M 172.60M
Diluted Earnings per Share
$0.38 $1.36 $2.61 $1.39 $2.44 $4.66 $4.72 $2.27 $0.57 ($1.10) ($1.65)
Weighted Average Diluted Shares Outstanding
245.40M 239.60M 243.90M 241.60M 230.60M 221.90M 221.40M 203M 177.40M 172.10M 172.60M
Weighted Average Basic & Diluted Shares Outstanding
244.70M 236.20M 238.20M 237.30M 225.10M 221.00M 214.37M 183.77M 172.28M 172.98M 174.01M

Quarterly Income Statements for Huntsman

This table shows Huntsman's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Total Costs & Expenses
- - - - - - 198 - - - 198
Net Income / (Loss) Attributable to Common Shareholders
-37 22 -33 -141 -5.00 -158 -25 -96 -53 -6.00 -18
Consolidated Net Income / (Loss)
-23 38 -17 -125 11 -145 -11 -82 -41 7.00 -5.00
Net Income / (Loss) Continuing Operations
-16 31 -5.00 -110 12 -146 -10 -74 -40 9.00 -2.00
Total Pre-Tax Income
-36 44 34 -81 27 -139 -7.00 -73 -29 26 26
Total Operating Income
-38 34 42 -63 42 -120 6.00 -59 -16 37 39
Total Gross Profit
201 243 234 188 201 182 204 164 183 245 237
Total Revenue
1,470 1,574 1,540 1,452 1,410 1,458 1,460 1,355 1,420 1,663 1,717
Operating Revenue
1,470 1,574 1,540 1,452 1,410 1,458 1,460 1,355 1,420 1,663 1,717
Total Cost of Revenue
1,269 1,331 1,306 1,264 1,209 1,276 1,256 1,191 1,237 1,418 1,480
Operating Cost of Revenue
1,269 1,331 1,306 1,264 1,209 1,276 1,256 1,191 1,237 1,418 1,480
Total Operating Expenses
239 209 192 251 159 302 198 223 199 208 198
Selling, General & Admin Expense
176 176 153 166 166 160 163 181 163 183 168
Research & Development Expense
31 33 27 30 32 33 29 26 29 28 27
Other Operating Expenses / (Income)
21 -4.00 7.00 36 -7.00 -15 -6.00 5.00 1.00 -12 -1.00
Restructuring Charge
11 4.00 5.00 - 1.00 124 12 - 6.00 9.00 4.00
Other Special Charges / (Income)
0.00 0.00 0.00 - -33 0.00 0.00 - - 0.00 0.00
Total Other Income / (Expense), net
2.00 10 -8.00 -18 -15 -19 -13 -14 -13 -11 -13
Interest & Investment Income
0.00 -2.00 -16 -17 -18 -23 -19 -15 -16 -18 -16
Other Income / (Expense), net
2.00 12 8.00 -1.00 3.00 4.00 6.00 1.00 3.00 7.00 3.00
Income Tax Expense
-20 13 39 29 15 7.00 3.00 1.00 11 17 28
Net Income / (Loss) Discontinued Operations
-7.00 7.00 -12 -15 -1.00 1.00 -1.00 -8.00 -1.00 -2.00 -3.00
Net Income / (Loss) Attributable to Noncontrolling Interest
14 16 16 16 16 13 14 14 12 13 13
Basic Earnings per Share
($0.22) $0.13 ($0.19) ($0.82) ($0.03) ($0.92) ($0.14) ($0.56) ($0.31) ($0.03) ($0.10)
Weighted Average Basic Shares Outstanding
171.80M 172.10M 172.10M 172.10M 172.40M 172.60M 172.60M 172.60M 173M 173.40M 173.40M
Diluted Earnings per Share
($0.22) $0.13 ($0.19) ($0.82) ($0.03) ($0.92) ($0.14) ($0.56) ($0.31) ($0.03) ($0.10)
Weighted Average Diluted Shares Outstanding
171.80M 172.80M 172.10M 172.10M 172.40M 172.60M 172.60M 172.60M 173M 173.40M 173.40M
Weighted Average Basic & Diluted Shares Outstanding
173.00M 173.00M 172.99M 172.98M 173.75M 173.75M 173.75M 174.01M 175.35M 175.38M 175.33M

Annual Cash Flow Statements for Huntsman

This table details how cash moves in and out of Huntsman's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-603 156 294 -190 185 1,068 -552 -387 -603 -200 89
Net Cash From Operating Activities
575 1,088 1,219 1,207 897 253 952 914 209 263 289
Net Cash From Continuing Operating Activities
614 974 672 704 656 231 915 892 251 285 298
Net Income / (Loss) Continuing Operations
428 365 511 689 429 289 1,055 511 35 -100 -218
Consolidated Net Income / (Loss)
126 357 741 650 598 1,066 1,104 523 153 -127 -227
Net Income / (Loss) Discontinued Operations
-302 -8.00 230 -39 169 777 49 12 118 -27 -9.00
Depreciation Expense
298 318 236 255 270 267 278 281 278 289 287
Non-Cash Adjustments To Reconcile Net Income
90 -51 79 21 70 54 3.00 164 134 167 196
Changes in Operating Assets and Liabilities, net
-202 342 -154 -261 -113 -379 -421 -64 -169 -130 38
Net Cash From Discontinued Operating Activities
-39 114 547 503 241 22 37 22 -42 -22 -9.00
Net Cash From Investing Activities
-600 -203 -424 -973 -260 1,463 -524 -279 305 -126 -132
Net Cash From Continuing Investing Activities
-404 -120 -217 -615 -201 1,474 -508 -260 309 -126 -132
Purchase of Property, Plant & Equipment
-461 -318 -234 -251 -274 -237 -326 -272 -230 -184 -173
Sale of Property, Plant & Equipment
- - 25 0.00 50 75 - 0.00 0.00 11 0.00
Other Investing Activities, net
-2.00 - -1.00 -1.00 7.00 6.00 20 12 -5.00 1.00 0.00
Net Cash From Discontinued Investing Activities
-196 -83 -207 -358 -59 -11 -16 -19 -4.00 0.00 0.00
Net Cash From Financing Activities
-562 -723 -519 -424 -450 -655 -977 -994 -620 -326 -76
Net Cash From Continuing Financing Activities
-562 -723 -519 -424 -450 -655 -977 -994 -792 -326 -76
Repayment of Debt
-689 -1,171 -2,162 -111 -821 -163 -1,020 -13 -61 -237 -329
Repurchase of Common Equity
-100 - - -277 -220 -104 -207 -1,019 -349 -9.00 -3.00
Payment of Dividends
-135 -150 -154 -255 -292 -188 -199 -187 -377 -260 -204
Issuance of Debt
372 600 815 202 881 -203 439 219 0.00 180 460
Issuance of Common Equity
1.00 1.00 1,052 17 2.00 3.00 10 6.00 5.00 0.00 0.00
Effect of Exchange Rate Changes
-16 -6.00 18 - -2.00 7.00 -3.00 -28 - -11 8.00
Cash Interest Paid
225 205 175 163 111 90 82 66 68 77 86
Cash Income Taxes Paid
126 40 25 179 100 316 106 194 97 90 98

Quarterly Cash Flow Statements for Huntsman

This table details how cash moves in and out of Huntsman's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-40 -260 -120 220 -60 22 160 -39 -60 -58 48
Net Cash From Operating Activities
-65 46 240 42 -74 91 196 76 -53 -60 110
Net Cash From Continuing Operating Activities
-63 55 261 32 -71 92 200 77 -53 -60 115
Net Income / (Loss) Continuing Operations
-16 31 8.00 -123 12 -146 -10 -74 -40 9.00 -2.00
Consolidated Net Income / (Loss)
-23 38 -16 -126 11 -145 -11 -82 -41 7.00 -5.00
Net Income / (Loss) Discontinued Operations
-7.00 7.00 -24 -3.00 -1.00 1.00 -1.00 -8.00 -1.00 -2.00 -3.00
Depreciation Expense
69 75 284 -139 69 72 73 73 73 77 77
Non-Cash Adjustments To Reconcile Net Income
34 70 188 -125 25 126 32 13 18 19 17
Changes in Operating Assets and Liabilities, net
-150 -121 -259 400 -177 40 110 65 -104 -165 23
Net Cash From Discontinued Operating Activities
-2.00 -9.00 -21 10 -3.00 -1.00 -4.00 -1.00 0.00 - -5.00
Net Cash From Investing Activities
-30 -50 -103 57 6.00 -38 -42 -58 -37 22 -33
Net Cash From Continuing Investing Activities
-39 -50 -103 57 1.00 -38 -80 -15 -37 17 -76
Purchase of Property, Plant & Equipment
-42 -50 -174 82 -36 -37 -43 -57 -38 -30 -33
Net Cash From Financing Activities
108 -210 -352 128 60 9.00 -83 -62 30 13 -65
Net Cash From Continuing Financing Activities
65 -253 -132 -6.00 11 -34 3.00 -62 30 -15 -37
Repayment of Debt
-33 -131 -488 55 -320 -2.00 -2.00 -5.00 -2.00 -7.00 43
Payment of Dividends
-87 -122 -9.00 -42 -87 -86 29 -60 -16 -44 7.00
Cash Interest Paid
12 29 69 -33 8.00 36 5.00 37 5.00 38 8.00
Cash Income Taxes Paid
15 29 76 -30 12 49 18 19 14 10 14

Annual Balance Sheets for Huntsman

This table presents Huntsman's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
9,820 9,189 10,244 7,953 8,320 8,713 9,392 16,446 14,501 14,228 14,030
Total Current Assets
3,834 3,555 5,979 2,958 3,755 3,568 3,928 6,296 4,633 4,250 4,128
Cash & Equivalents
257 385 470 340 525 1,593 1,041 1,308 1,080 680 858
Note & Lease Receivable
1,420 1,168 1,256 1,165 940 902 988 1,626 1,494 1,436 1,340
Accounts Receivable
29 15 27 18 13 8.00 27 42 12 14 14
Inventories, net
1,692 918 1,073 1,000 914 848 1,038 1,990 1,734 1,834 1,636
Prepaid Expenses
112 49 60 58 - - - - 184 228 188
Other Current Assets
312 232 202 145 155 217 834 1,330 129 58 92
Plant, Property, & Equipment, net
4,446 3,034 3,098 2,353 0.00 2,505 2,443 4,754 4,752 4,986 4,972
Total Noncurrent Assets
1,540 2,600 1,167 2,642 4,565 2,640 3,021 5,396 5,116 4,992 4,930
Long-Term Investments
347 248 266 526 535 373 470 850 876 692 618
Goodwill
116 121 140 275 276 533 650 1,282 1,288 1,266 1,260
Intangible Assets
86 43 56 213 197 453 469 850 774 688 616
Noncurrent Deferred & Refundable Income Taxes
418 253 208 324 292 288 180 294 224 138 98
Other Noncurrent Operating Assets
573 472 497 427 3,265 993 1,070 2,120 1,954 2,208 2,338
Total Liabilities & Shareholders' Equity
9,820 9,189 10,244 7,953 8,320 8,713 9,392 16,446 14,501 14,228 14,030
Total Liabilities
8,191 7,722 6,873 5,204 5,496 5,040 4,833 8,754 7,532 7,895 8,109
Total Current Liabilities
1,917 1,778 3,265 1,611 2,008 1,979 2,051 3,400 2,338 3,125 3,175
Short-Term Debt
170 50 40 96 212 593 12 132 24 650 706
Accounts Payable
1,061 790 964 793 822 876 1,114 1,922 1,437 1,540 1,516
Accrued Expenses
686 471 569 497 420 458 713 856 785 827 839
Other Current Liabilities
- - - - 42 52 49 102 92 108 114
Total Noncurrent Liabilities
6,274 5,944 3,608 3,593 3,488 3,061 2,782 5,354 5,194 4,770 4,934
Long-Term Debt
4,626 4,123 2,258 2,224 2,177 1,528 1,538 3,342 3,352 3,020 3,316
Noncurrent Deferred & Payable Income Tax Liabilities
422 371 264 137 29 212 161 504 490 411 316
Other Noncurrent Operating Liabilities
1,226 1,057 1,086 949 1,282 910 932 1,508 1,352 1,339 1,302
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,629 1,467 3,371 2,749 2,824 3,673 4,559 7,692 6,969 6,333 5,921
Total Preferred & Common Equity
1,442 1,287 2,620 2,520 2,687 3,519 4,378 3,624 3,251 2,959 2,750
Total Common Equity
1,442 1,287 2,620 2,520 2,687 3,519 4,378 3,636 3,264 2,966 2,757
Common Stock
3,410 3,450 3,892 3,987 4,011 4,051 4,105 7,918 7,990 8,050 8,107
Retained Earnings
-528 -325 161 292 690 1,564 2,435 3,835 3,331 2,582 1,714
Treasury Stock
-135 -150 -150 -427 -635 -731 -934 -1,937 -2,290 -2,290 -2,290
Accumulated Other Comprehensive Income / (Loss)
-1,288 -1,671 -1,268 -1,316 -1,362 -1,346 -1,203 -2,521 -2,475 -2,385 -1,996
Other Equity Adjustments
-17 -17 -15 -16 -17 -19 -25 -35 -41 -32 -28
Noncontrolling Interest
187 180 751 229 137 154 181 432 454 408 414

Quarterly Balance Sheets for Huntsman

This table presents Huntsman's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
7,553 14,737 15,149 14,639 14,673 14,464 14,294 14,164 14,262 14,380 14,208
Total Current Assets
2,520 4,787 4,891 4,513 4,591 4,572 4,416 4,364 4,358 4,556 4,480
Cash & Equivalents
502 992 1,104 670 660 668 798 936 738 692 718
Note & Lease Receivable
856 1,644 1,662 1,740 1,644 1,578 1,610 1,522 1,538 1,742 1,720
Accounts Receivable
0.00 10 12 14 14 16 16 14 14 18 20
Inventories, net
1,012 1,882 1,792 1,846 2,008 2,060 1,792 1,672 1,770 1,870 1,810
Prepaid Expenses
- - - - - 190 138 114 208 158 144
Other Current Assets
145 259 321 243 265 60 62 106 90 76 68
Plant, Property, & Equipment, net
2,354 4,626 5,142 5,098 5,160 4,988 4,982 4,950 4,882 4,816 4,738
Total Noncurrent Assets
2,679 5,324 5,116 5,028 4,922 4,904 4,896 4,850 5,022 5,008 4,990
Long-Term Investments
425 900 914 840 722 634 598 602 638 648 668
Goodwill
643 1,278 1,280 1,280 1,286 1,274 1,262 1,256 1,256 1,244 1,244
Intangible Assets
406 790 756 732 716 668 656 634 596 570 550
Noncurrent Deferred & Refundable Income Taxes
128 252 218 218 216 122 132 126 94 88 90
Other Noncurrent Operating Assets
1,077 2,104 1,948 1,958 1,982 2,206 2,248 2,232 2,438 2,458 2,438
Total Liabilities & Shareholders' Equity
7,553 14,737 15,149 14,639 14,673 14,464 14,294 14,164 14,262 14,380 14,208
Total Liabilities
3,707 7,416 8,352 7,958 7,971 8,120 8,165 8,155 8,454 8,518 8,390
Total Current Liabilities
1,176 2,529 3,153 3,453 3,115 3,075 3,085 3,199 3,435 3,435 3,319
Short-Term Debt
11 226 792 1,152 692 568 744 756 752 728 606
Accounts Payable
0.00 1,449 1,490 1,462 1,490 1,476 1,388 1,376 1,686 1,772 1,724
Accrued Expenses
374 762 767 733 823 915 839 953 883 825 875
Other Current Liabilities
46 92 104 106 110 116 114 114 114 110 114
Total Noncurrent Liabilities
2,531 4,887 5,199 4,505 4,856 5,045 5,080 4,956 5,019 5,083 5,071
Long-Term Debt
1,562 2,986 3,320 2,688 3,026 3,340 3,326 3,260 3,360 3,446 3,480
Noncurrent Deferred & Payable Income Tax Liabilities
243 514 455 447 501 386 383 358 297 298 317
Other Noncurrent Operating Liabilities
726 1,387 1,424 1,370 1,329 1,319 1,371 1,338 1,362 1,339 1,274
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,846 7,321 6,797 6,681 6,702 6,344 6,129 6,009 5,808 5,862 5,818
Total Preferred & Common Equity
3,615 3,429 3,152 3,114 3,112 2,951 2,828 2,766 2,681 2,692 2,662
Total Common Equity
3,615 3,442 3,161 3,123 3,124 2,953 2,835 2,773 2,685 2,696 2,664
Common Stock
4,198 7,983 8,027 8,035 8,042 8,084 8,092 8,098 8,149 8,156 8,163
Retained Earnings
2,781 3,609 3,150 3,108 2,956 2,477 2,076 1,939 1,576 1,532 1,464
Treasury Stock
-2,136 -2,239 -2,290 -2,290 -2,290 -2,290 -2,290 -2,290 -2,290 -2,290 -2,290
Accumulated Other Comprehensive Income / (Loss)
-1,175 -2,435 -2,523 -2,571 -2,433 -2,319 -2,173 -2,173 -2,019 -1,967 -1,975
Other Equity Adjustments
-53 -47 -51 -45 -39 -48 -42 -35 -50 -43 -36
Noncontrolling Interest
231 450 484 444 466 440 466 470 442 474 492

Annual Metrics And Ratios for Huntsman

This table displays calculated financial ratios and metrics derived from Huntsman's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 173,751,026.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 173,751,026.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -1.63
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-29.70% -7.63% -8.95% 11.09% -10.61% -20.24% 41.49% 4.60% -23.83% -1.23% -5.85%
EBITDA Growth
-5.58% -2.26% -2.01% 14.49% -31.87% -3.82% 42.19% -6.26% -63.10% -20.61% -40.35%
EBIT Growth
13.79% -5.99% 9.19% 16.55% -43.07% -5.32% 64.15% -8.95% -88.29% -104.94% -2,825.00%
NOPAT Growth
13.70% -18.81% 37.41% 10.66% -33.71% -26.70% 64.10% -20.40% -93.97% -158.93% -424.00%
Net Income Growth
-63.48% 183.33% 107.56% 33.20% -39.41% 78.26% 3.56% -52.63% -70.75% -183.01% -78.74%
EPS Growth
-70.99% 257.89% 91.91% -46.74% 75.54% 90.98% 1.29% -51.91% -74.89% -292.98% -50.00%
Operating Cash Flow Growth
-24.34% 89.22% 12.04% -0.98% -25.68% -71.79% 276.28% -3.99% -77.13% 25.84% 9.89%
Free Cash Flow Firm Growth
1,017.14% 298.84% -78.42% 55.65% -27.38% -161.37% 131.61% -3,361.82% 124.84% -125.03% 127.86%
Invested Capital Growth
-0.84% -37.75% 3.26% -3.54% -4.03% 22.62% 11.58% 98.65% -10.72% 2.88% -1.90%
Revenue Q/Q Growth
-25.45% 8.92% -1.41% 3.36% 0.00% 0.00% 9.12% -0.77% -3.88% 0.82% -1.68%
EBITDA Q/Q Growth
17.59% 1.43% -15.61% -2.71% 182.16% 165.45% 29.91% -16.62% -12.44% -43.90% 454.17%
EBIT Q/Q Growth
57.11% -8.78% -12.05% -10.24% 0.00% 0.00% 42.59% -21.98% -36.72% -140.00% 4.88%
NOPAT Q/Q Growth
191.02% -25.54% 3.36% -17.50% 0.00% 0.00% 16.12% -31.18% -1.16% -56.25% 2.96%
Net Income Q/Q Growth
53.66% 55.90% 25.38% -21.17% 0.00% 0.00% 148.09% -56.56% 10.87% -108.20% 15.93%
EPS Q/Q Growth
80.95% 60.00% 22.54% -63.23% 0.00% 0.00% 32.21% -57.57% 0.00% -69.23% 13.61%
Operating Cash Flow Q/Q Growth
-28.48% 5.02% 24.01% -14.40% -3.44% -23.10% 191.13% -34.43% -41.13% -31.69% 13.33%
Free Cash Flow Firm Q/Q Growth
655.98% 141.89% -76.49% 266.31% 60.48% -1,020.04% 186.45% -913.70% 126.98% 36.43% -84.16%
Invested Capital Q/Q Growth
-1.24% -33.65% 2.39% -17.00% -12.01% 9.11% 3.59% 97.02% -2.92% -4.50% -0.24%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
21.30% 20.19% 24.12% 23.20% 20.33% 18.02% 20.65% 19.27% 14.83% 14.35% 13.21%
EBITDA Margin
12.48% 13.21% 14.21% 14.65% 11.17% 13.47% 13.53% 12.13% 5.87% 4.72% 2.99%
Operating Margin
8.81% 8.82% 10.65% 10.88% 6.90% 7.97% 9.53% 8.38% 1.37% -0.41% -2.31%
EBIT Margin
8.82% 8.98% 10.77% 11.30% 7.19% 8.54% 9.91% 8.63% 1.33% -0.07% -2.06%
Profit (Net Income) Margin
1.55% 4.75% 10.83% 12.98% 8.80% 19.66% 14.39% 6.52% 2.50% -2.10% -3.99%
Tax Burden Percent
25.82% 75.32% 139.55% 134.47% 152.94% 322.05% 88.60% 75.04% 154.55% 325.64% 118.23%
Interest Burden Percent
67.97% 70.22% 72.05% 85.45% 79.96% 71.49% 163.95% 100.72% 122.22% 975.00% 164.10%
Effective Tax Rate
12.30% 23.00% 3.77% 6.13% -9.72% 12.69% 15.33% 26.69% 64.65% 0.00% 0.00%
Return on Invested Capital (ROIC)
10.78% 10.83% 19.09% 21.16% 14.58% 9.80% 13.80% 6.98% 0.33% -0.21% -1.07%
ROIC Less NNEP Spread (ROIC-NNEP)
-1.66% 5.98% 22.23% 55.82% 25.81% 124.70% 145.43% 10.21% 8.23% -6.10% -6.66%
Return on Net Nonoperating Assets (RNNOA)
-3.74% 12.23% 11.54% 11.09% 6.88% 23.01% 13.02% 1.56% 1.75% -1.70% -2.63%
Return on Equity (ROE)
7.04% 23.06% 30.63% 32.25% 21.46% 32.82% 26.82% 8.54% 2.09% -1.91% -3.70%
Cash Return on Invested Capital (CROIC)
11.62% 57.37% 15.88% 24.76% 18.69% -10.52% 2.85% -59.09% 11.66% -3.05% 0.85%
Operating Return on Assets (OROA)
6.92% 7.10% 7.59% 9.44% 6.01% 5.44% 8.40% 5.36% 0.52% -0.03% -0.83%
Return on Assets (ROA)
1.21% 3.76% 7.63% 10.85% 7.35% 12.52% 12.20% 4.05% 0.99% -0.88% -1.61%
Return on Common Equity (ROCE)
6.33% 20.33% 24.74% 27.09% 20.05% 31.35% 25.73% 5.59% 0.98% -0.89% -1.73%
Return on Equity Simple (ROE_SIMPLE)
8.74% 27.74% 28.28% 39.17% 22.26% 30.29% 25.22% 14.43% 4.71% -4.29% 0.00%
Net Operating Profit after Tax (NOPAT)
629 511 702 776 515 377 619 493 30 -18 -92
NOPAT Margin
7.73% 6.79% 10.25% 10.21% 7.57% 6.96% 8.07% 6.14% 0.49% -0.29% -1.61%
Net Nonoperating Expense Percent (NNEP)
12.44% 4.85% -3.14% -34.65% -11.23% -114.90% -131.63% -3.24% -7.89% 5.89% 5.59%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 4.41% 0.29% -0.17% -0.92%
Cost of Revenue to Revenue
78.70% 79.81% 75.88% 76.80% 79.67% 81.98% 79.35% 80.73% 85.17% 85.65% 86.79%
SG&A Expenses to Revenue
9.72% 10.27% 11.09% 10.38% 11.56% 12.36% 9.63% 8.86% 11.27% 11.12% 11.79%
R&D to Revenue
1.76% 1.82% 1.93% 1.91% 2.02% 2.23% 1.76% 1.56% 1.88% 2.00% 2.11%
Operating Expenses to Revenue
12.50% 11.37% 13.47% 12.36% 13.43% 10.05% 11.12% 10.89% 13.45% 14.76% 15.52%
Earnings before Interest and Taxes (EBIT)
718 675 737 859 489 463 760 692 81 -4.00 -117
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,016 993 973 1,114 759 730 1,038 973 359 285 170
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.51 2.84 2.50 1.54 1.76 1.41 1.60 1.34 1.28 1.05 0.62
Price to Tangible Book Value (P/TBV)
1.75 3.26 2.71 1.90 2.13 1.96 2.14 3.23 3.48 3.08 1.95
Price to Revenue (P/Rev)
0.27 0.49 0.96 0.51 0.69 0.92 0.91 0.61 0.69 0.52 0.30
Price to Earnings (P/E)
23.39 11.23 10.32 5.74 8.40 4.81 6.68 10.57 41.46 0.00 0.00
Dividend Yield
5.64% 3.25% 1.83% 4.00% 3.10% 2.89% 2.26% 3.36% 3.95% 5.55% 8.48%
Earnings Yield
4.28% 8.91% 9.69% 17.42% 11.91% 20.80% 14.96% 9.46% 2.41% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.13 2.04 2.37 1.54 1.79 1.34 1.52 0.70 0.72 0.67 0.55
Enterprise Value to Revenue (EV/Rev)
0.80 0.98 1.30 0.73 0.91 1.05 0.94 0.82 0.99 0.97 0.82
Enterprise Value to EBITDA (EV/EBITDA)
6.44 7.42 9.11 4.98 8.15 7.79 6.94 6.80 16.89 20.44 27.51
Enterprise Value to EBIT (EV/EBIT)
9.11 10.92 12.03 6.46 12.65 12.29 9.48 9.56 74.84 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
10.40 14.43 12.64 7.15 12.02 15.09 11.64 13.42 204.13 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
11.38 6.77 7.27 4.60 6.90 22.49 7.57 7.23 29.00 22.15 16.18
Enterprise Value to Free Cash Flow (EV/FCFF)
9.65 2.73 15.19 6.11 9.38 0.00 56.31 0.00 5.85 0.00 64.68
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.94 2.84 0.68 0.84 0.85 0.69 0.34 0.45 0.48 0.58 0.68
Long-Term Debt to Equity
2.84 2.81 0.67 0.81 0.77 0.53 0.34 0.43 0.48 0.48 0.56
Financial Leverage
2.26 2.04 0.52 0.20 0.27 0.18 0.09 0.15 0.21 0.28 0.40
Leverage Ratio
5.79 6.14 4.02 2.97 2.92 2.62 2.20 2.11 2.11 2.16 2.31
Compound Leverage Factor
3.94 4.31 2.89 2.54 2.33 1.87 3.61 2.12 2.58 21.06 3.78
Debt to Total Capital
74.65% 73.99% 40.54% 45.77% 45.83% 40.81% 25.37% 31.11% 32.63% 36.69% 40.45%
Short-Term Debt to Total Capital
2.65% 0.89% 0.71% 1.89% 4.07% 9.56% 0.20% 1.18% 0.23% 6.50% 7.10%
Long-Term Debt to Total Capital
72.00% 73.10% 39.83% 43.87% 41.76% 31.25% 25.18% 29.93% 32.40% 30.19% 33.35%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.91% 3.19% 13.25% 4.52% 2.63% 2.48% 2.96% 3.87% 4.39% 4.08% 4.16%
Common Equity to Total Capital
22.44% 22.82% 46.22% 49.71% 51.54% 56.71% 71.66% 32.56% 31.55% 29.65% 27.73%
Debt to EBITDA
4.72 4.20 2.36 2.08 3.15 3.47 1.49 3.57 9.40 12.88 23.66
Net Debt to EBITDA
4.11 3.55 1.59 1.31 1.75 0.78 0.04 1.35 3.96 8.06 14.98
Long-Term Debt to EBITDA
4.55 4.15 2.32 2.00 2.87 2.66 1.48 3.43 9.34 10.60 19.51
Debt to NOPAT
7.63 8.17 3.28 2.99 4.64 6.71 2.50 7.05 113.68 -209.71 -43.86
Net Debt to NOPAT
6.65 6.91 2.21 1.87 2.58 1.50 0.06 2.67 47.82 -131.31 -27.76
Long-Term Debt to NOPAT
7.36 8.08 3.22 2.86 4.23 5.14 2.48 6.78 112.87 -172.57 -36.16
Altman Z-Score
1.39 1.53 1.82 2.01 1.89 1.86 2.55 1.50 1.29 1.01 0.76
Noncontrolling Interest Sharing Ratio
10.06% 11.85% 19.24% 16.01% 6.57% 4.48% 4.07% 34.58% 52.94% 53.16% 53.30%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.00 2.00 1.83 1.84 1.87 1.80 1.92 1.85 1.98 1.36 1.30
Quick Ratio
0.89 0.88 0.54 0.95 0.74 1.26 1.00 0.88 1.11 0.68 0.70
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
678 2,704 584 908 660 -405 128 -4,173 1,037 -260 72
Operating Cash Flow to CapEx
124.73% 342.14% 583.25% 480.88% 400.45% 156.17% 292.02% 336.03% 90.87% 152.02% 167.05%
Free Cash Flow to Firm to Interest Expense
21.87 901.18 10.81 0.00 28.68 0.00 4.74 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
18.55 362.67 22.57 0.00 39.00 0.00 35.26 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
3.68 256.67 18.70 0.00 29.26 0.00 23.19 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.78 0.79 0.70 0.84 0.84 0.64 0.85 0.62 0.39 0.42 0.40
Accounts Receivable Turnover
229.27 341.73 325.95 337.96 438.52 516.29 438.29 232.55 226.33 464.31 405.93
Inventory Turnover
3.45 4.60 5.22 5.63 5.66 5.04 6.45 4.28 2.80 2.90 2.84
Fixed Asset Turnover
1.84 2.01 2.23 2.79 0.00 0.00 3.10 2.23 1.29 1.24 1.14
Accounts Payable Turnover
5.48 6.48 5.92 6.65 6.71 5.23 6.12 4.27 3.10 3.47 3.23
Days Sales Outstanding (DSO)
1.59 1.07 1.12 1.08 0.83 0.71 0.83 1.57 1.61 0.79 0.90
Days Inventory Outstanding (DIO)
105.91 79.39 69.96 64.78 64.51 72.36 56.56 85.32 130.57 125.95 128.40
Days Payable Outstanding (DPO)
66.56 56.30 61.63 54.91 54.43 69.73 59.67 85.54 117.77 105.09 113.08
Cash Conversion Cycle (CCC)
40.94 24.15 9.45 10.96 10.91 3.34 -2.29 1.34 14.41 21.65 16.22
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,809 3,616 3,734 3,602 3,457 4,239 4,730 9,396 8,389 8,631 8,467
Invested Capital Turnover
1.40 1.60 1.86 2.07 1.93 1.41 1.71 1.14 0.69 0.71 0.66
Increase / (Decrease) in Invested Capital
-49 -2,193 118 -132 -145 782 491 4,666 -1,007 242 -164
Enterprise Value (EV)
6,542 7,369 8,865 5,551 6,186 5,690 7,204 6,612 6,062 5,825 4,676
Market Capitalization
2,175 3,660 6,563 3,868 4,720 4,970 6,984 4,864 4,188 3,119 1,716
Book Value per Share
$5.88 $5.40 $10.92 $10.57 $11.92 $15.94 $20.08 $18.93 $18.73 $17.15 $15.87
Tangible Book Value per Share
$5.05 $4.72 $10.10 $8.53 $9.82 $11.47 $14.95 $7.83 $6.90 $5.85 $5.07
Total Capital
6,425 5,640 5,669 5,069 5,213 6,205 6,109 11,166 10,345 10,003 9,943
Total Debt
4,796 4,173 2,298 2,320 2,389 2,532 1,550 3,474 3,376 3,670 4,022
Total Long-Term Debt
4,626 4,123 2,258 2,224 2,177 1,939 1,538 3,342 3,352 3,020 3,316
Net Debt
4,180 3,529 1,551 1,454 1,329 566 39 1,316 1,420 2,298 2,546
Capital Expenditures (CapEx)
461 318 209 251 224 162 326 272 230 173 173
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,818 1,431 2,273 1,103 1,434 589 848 1,720 1,239 1,095 801
Debt-free Net Working Capital (DFNWC)
2,087 1,827 2,754 1,443 1,959 2,182 1,889 3,028 2,319 1,775 1,659
Net Working Capital (NWC)
1,917 1,777 2,714 1,347 1,747 1,589 1,877 2,896 2,295 1,125 953
Net Nonoperating Expense (NNE)
503 154 -39 -211 -83 -689 -485 -30 -123 110 135
Net Nonoperating Obligations (NNO)
4,180 2,149 363 853 633 566 171 1,704 1,420 2,298 2,546
Total Depreciation and Amortization (D&A)
298 318 236 255 270 267 278 281 278 289 287
Debt-free, Cash-free Net Working Capital to Revenue
22.34% 19.03% 33.21% 14.51% 21.10% 10.87% 11.06% 21.44% 20.27% 18.14% 14.09%
Debt-free Net Working Capital to Revenue
25.64% 24.30% 40.23% 18.98% 28.82% 40.25% 24.63% 37.74% 37.95% 29.41% 29.19%
Net Working Capital to Revenue
23.55% 23.64% 39.65% 17.71% 25.70% 29.31% 24.47% 36.10% 37.56% 18.64% 16.77%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.38 $1.38 $2.67 $1.42 $2.46 $4.69 $4.77 $2.29 $0.57 ($1.10) ($1.65)
Adjusted Weighted Average Basic Shares Outstanding
242.80M 236.30M 238.40M 238.10M 228.90M 220.60M 219.20M 201M 177.40M 172.10M 172.60M
Adjusted Diluted Earnings per Share
$0.38 $1.36 $2.61 $1.39 $2.44 $4.66 $4.72 $2.27 $0.57 ($1.10) ($1.65)
Adjusted Weighted Average Diluted Shares Outstanding
245.40M 239.60M 243.90M 241.60M 230.60M 221.90M 221.40M 203M 177.40M 172.10M 172.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
236.88M 238.51M 241.72M 233.38M 225.10M 221.00M 214.37M 183.77M 172.28M 172.98M 174.01M
Normalized Net Operating Profit after Tax (NOPAT)
702 547 747 774 300 413 653 556 71 9.80 -11
Normalized NOPAT Margin
8.62% 7.27% 10.91% 10.18% 4.41% 7.62% 8.51% 6.93% 1.17% 0.16% -0.20%
Pre Tax Income Margin
6.00% 6.30% 7.76% 9.65% 5.75% 6.11% 16.25% 8.69% 1.62% -0.65% -3.38%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
23.16 225.00 13.65 0.00 21.26 0.00 28.15 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
20.29 170.18 12.99 0.00 22.37 0.00 22.92 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
8.29 119.00 9.78 0.00 11.52 0.00 16.07 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
5.41 64.18 9.12 0.00 12.63 0.00 10.85 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
107.14% 42.02% 20.78% 25.84% 48.83% 17.64% 18.03% 35.76% 246.41% -204.72% -89.87%
Augmented Payout Ratio
186.51% 42.02% 20.78% 53.90% 85.62% 27.39% 36.78% 230.59% 474.51% -211.81% -91.19%

Quarterly Metrics And Ratios for Huntsman

This table displays calculated financial ratios and metrics derived from Huntsman's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - 173,751,026.00 174,009,349.00 175,349,112.00 175,378,616.00
DEI Adjusted Shares Outstanding
- - - - - - - 173,751,026.00 174,009,349.00 175,349,112.00 175,378,616.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - -0.55 -0.30 -0.03 -0.10
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-8.47% -1.38% 2.26% 3.49% -4.08% -7.37% -5.19% -6.68% 0.71% 14.06% 17.60%
EBITDA Growth
-74.62% 2.54% 247.92% -1,453.33% 245.45% -136.36% -74.55% 107.39% -47.37% 375.00% 40.00%
EBIT Growth
-159.02% -4.17% 85.19% -16.36% 225.00% -352.17% -76.00% 9.38% -128.89% 137.93% 250.00%
NOPAT Growth
-154.51% -11.44% -164.05% -16.67% 170.18% -450.66% 168.00% 6.35% -160.00% 115.25% -171.43%
Net Income Growth
-113.86% 22.58% -213.33% -111.86% 147.83% -481.58% 35.29% 34.40% -472.73% 104.83% 54.55%
EPS Growth
-126.51% 18.18% 0.00% -121.62% 86.36% -807.69% 26.32% 31.71% -933.33% 96.74% 28.57%
Operating Cash Flow Growth
57.79% 27.78% 47.24% -74.39% -13.85% 97.83% -18.33% 80.95% 28.38% -165.93% -43.88%
Free Cash Flow Firm Growth
-363.11% -909.55% 89.56% -129.52% 99.39% 103.30% 237.71% 142.89% 1,078.84% -3.38% -106.12%
Invested Capital Growth
278.18% 72.23% 4.59% 2.88% 0.66% -2.31% -6.10% -1.90% -4.54% -1.22% 0.37%
Revenue Q/Q Growth
4.78% 7.07% -2.16% -5.71% -2.89% 3.40% 0.14% -7.19% 0.00% 17.11% 3.25%
EBITDA Q/Q Growth
65.00% 266.67% 176.03% -160.78% 156.16% -138.60% 293.18% -82.35% 0.00% 101.67% -1.65%
EBIT Q/Q Growth
28.00% 227.78% 8.70% -228.00% 170.31% -357.78% 110.34% -583.33% 0.00% 438.46% -4.55%
NOPAT Q/Q Growth
29.63% 190.05% -125.78% -614.00% 142.33% -550.00% 105.00% -1,083.33% 0.00% 214.35% -123.42%
Net Income Q/Q Growth
61.02% 265.22% -144.74% -635.29% 108.80% -1,418.18% 92.41% -645.45% 0.00% 117.07% -171.43%
EPS Q/Q Growth
40.54% 159.09% -246.15% -331.58% 96.34% -2,966.67% 84.78% -300.00% 0.00% 90.32% -233.33%
Operating Cash Flow Q/Q Growth
-139.63% 170.77% 421.74% -82.50% -276.19% 222.97% 115.38% -61.22% 0.00% -13.21% 283.33%
Free Cash Flow Firm Q/Q Growth
-777.53% 42.82% 89.26% 29.04% 85.90% 407.44% 347.74% -77.90% 0.00% -69.65% -128.38%
Invested Capital Q/Q Growth
5.98% 1.35% 0.30% -4.50% 3.70% -1.64% -3.59% -0.24% 0.00% 1.78% -2.05%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
13.67% 15.44% 15.19% 12.95% 14.26% 12.48% 13.97% 12.10% 12.89% 14.73% 13.80%
EBITDA Margin
2.24% 7.69% 21.69% -13.98% 8.09% -3.02% 5.82% 1.11% 4.23% 7.28% 6.93%
Operating Margin
-2.59% 2.16% 2.73% -4.34% 2.98% -8.23% 0.41% -4.35% -1.13% 2.22% 2.27%
EBIT Margin
-2.45% 2.92% 3.25% -4.41% 3.19% -7.96% 0.82% -4.28% -0.92% 2.65% 2.45%
Profit (Net Income) Margin
-1.56% 2.41% -1.10% -8.61% 0.78% -9.95% -0.75% -6.05% -2.89% 0.42% -0.29%
Tax Burden Percent
63.89% 86.36% -50.00% 154.32% 40.74% 104.32% 157.14% 112.33% 141.38% 26.92% -19.23%
Interest Burden Percent
100.00% 95.65% 68.00% 126.56% 60.00% 119.83% -58.33% 125.86% 223.08% 59.09% 61.90%
Effective Tax Rate
0.00% 29.55% 114.71% 0.00% 55.56% 0.00% 0.00% 0.00% 0.00% 65.38% 107.69%
Return on Invested Capital (ROIC)
-1.92% 1.27% -0.27% -2.15% 0.89% -3.79% 0.19% -2.03% 0.00% 0.00% -0.13%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.34% 2.03% -0.86% -6.51% 0.56% -6.23% -0.44% -3.71% 0.00% 0.00% -0.20%
Return on Net Nonoperating Assets (RNNOA)
-0.01% 0.72% -0.23% -1.82% 0.20% -2.43% -0.17% -1.47% 0.00% 0.00% -0.09%
Return on Equity (ROE)
-1.94% 1.99% -0.50% -3.97% 1.09% -6.22% 0.02% -3.49% 0.00% 0.00% -0.22%
Cash Return on Invested Capital (CROIC)
-115.52% -53.37% -4.62% -3.05% -2.51% 1.56% 5.21% 0.85% 4.64% 1.22% -0.36%
Operating Return on Assets (OROA)
-1.64% 1.57% 1.32% -1.85% 1.29% -3.22% 0.33% -1.72% 0.00% 0.00% 1.06%
Return on Assets (ROA)
-1.05% 1.30% -0.45% -3.62% 0.31% -4.03% -0.30% -2.43% 0.00% 0.00% -0.13%
Return on Common Equity (ROCE)
-0.95% 1.27% -0.23% -1.86% 0.51% -2.89% 0.01% -1.63% 0.00% 0.00% -0.10%
Return on Equity Simple (ROE_SIMPLE)
-1.14% -0.93% -1.96% 0.00% -3.15% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-27 24 -6.18 -44 19 -84 4.20 -41 -11 13 -3.00
NOPAT Margin
-1.81% 1.52% -0.40% -3.04% 1.32% -5.76% 0.29% -3.05% -0.79% 0.77% -0.17%
Net Nonoperating Expense Percent (NNEP)
-1.58% -0.76% 0.59% 4.35% 0.33% 2.44% 0.63% 1.68% 1.12% 0.21% 0.08%
Return On Investment Capital (ROIC_SIMPLE)
- - - -0.44% 0.18% -0.82% 0.04% -0.42% -0.11% 0.13% -0.03%
Cost of Revenue to Revenue
86.33% 84.56% 84.81% 87.05% 85.74% 87.52% 86.03% 87.90% 87.11% 85.27% 86.20%
SG&A Expenses to Revenue
11.97% 11.18% 9.94% 11.43% 11.77% 10.97% 11.16% 13.36% 11.48% 11.00% 9.78%
R&D to Revenue
2.11% 2.10% 1.75% 2.07% 2.27% 2.26% 1.99% 1.92% 2.04% 1.68% 1.57%
Operating Expenses to Revenue
16.26% 13.28% 12.47% 17.29% 11.28% 20.71% 13.56% 16.46% 14.01% 12.51% 11.53%
Earnings before Interest and Taxes (EBIT)
-36 46 50 -64 45 -116 12 -58 -13 44 42
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
33 121 334 -203 114 -44 85 15 60 121 119
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.42 1.26 1.34 1.05 0.93 0.64 0.56 0.62 0.86 0.69 0.55
Price to Tangible Book Value (P/TBV)
3.99 3.55 3.73 3.08 2.70 1.97 1.77 1.95 2.78 2.11 1.69
Price to Revenue (P/Rev)
0.75 0.66 0.70 0.52 0.46 0.31 0.27 0.30 0.00 0.00 0.24
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
3.74% 4.28% 4.08% 5.55% 6.33% 9.60% 11.14% 8.48% 5.07% 4.83% 4.17%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.79 0.75 0.77 0.67 0.65 0.56 0.53 0.55 0.64 0.59 0.55
Enterprise Value to Revenue (EV/Rev)
1.18 1.13 1.17 0.97 0.97 0.84 0.78 0.82 0.00 0.00 0.76
Enterprise Value to EBITDA (EV/EBITDA)
26.47 24.86 13.76 20.44 15.79 24.63 0.00 27.51 0.00 0.00 14.81
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 698.87 0.00 75.03 0.00 0.00 0.00 0.00 0.00 311.01
Enterprise Value to NOPAT (EV/NOPAT)
150.78 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6,664.54
Enterprise Value to Operating Cash Flow (EV/OCF)
23.72 21.80 18.15 22.15 22.75 16.56 17.68 16.18 0.00 0.00 63.91
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 35.69 9.88 64.68 13.53 48.32 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.61 0.57 0.55 0.58 0.62 0.66 0.67 0.68 0.71 0.71 0.70
Long-Term Debt to Equity
0.49 0.40 0.45 0.48 0.53 0.54 0.54 0.56 0.58 0.59 0.60
Financial Leverage
0.04 0.35 0.26 0.28 0.36 0.39 0.38 0.40 0.44 0.46 0.44
Leverage Ratio
1.66 2.11 2.10 2.16 2.25 2.26 2.27 2.31 2.36 2.39 2.40
Compound Leverage Factor
1.66 2.02 1.43 2.73 1.35 2.71 -1.32 2.90 5.27 1.41 1.49
Debt to Total Capital
37.69% 36.50% 35.68% 36.69% 38.12% 39.91% 40.06% 40.45% 41.45% 41.59% 41.26%
Short-Term Debt to Total Capital
7.26% 10.95% 6.64% 6.50% 5.54% 7.29% 7.54% 7.10% 7.58% 7.25% 6.12%
Long-Term Debt to Total Capital
30.43% 25.55% 29.04% 30.19% 32.58% 32.61% 32.52% 33.35% 33.87% 34.34% 35.14%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
4.44% 4.22% 4.47% 4.08% 4.29% 4.57% 4.69% 4.16% 4.46% 4.72% 4.97%
Common Equity to Total Capital
28.98% 29.68% 29.98% 29.65% 28.80% 27.80% 27.66% 27.73% 27.07% 26.86% 26.90%
Debt to EBITDA
15.40 14.22 7.32 12.88 10.68 20.25 -83.67 23.66 0.00 0.00 12.97
Net Debt to EBITDA
7.84 8.63 4.60 8.06 7.12 13.30 -51.63 14.98 0.00 0.00 8.57
Long-Term Debt to EBITDA
12.43 9.96 5.96 10.60 9.13 16.55 -67.92 19.51 0.00 0.00 11.05
Debt to NOPAT
87.72 -176.96 -331.96 -209.71 -23.68 -58.73 -42.50 -43.86 0.00 0.00 5,837.14
Net Debt to NOPAT
44.67 -107.37 -208.57 -131.31 -15.79 -38.59 -26.22 -27.76 0.00 0.00 3,857.14
Long-Term Debt to NOPAT
70.83 -123.87 -270.18 -172.57 -20.24 -47.99 -34.50 -36.16 0.00 0.00 4,971.43
Altman Z-Score
1.14 1.10 1.14 1.00 0.99 0.83 0.82 0.77 0.39 0.38 0.79
Noncontrolling Interest Sharing Ratio
51.21% 35.99% 53.18% 53.16% 53.47% 53.49% 53.61% 53.30% 53.60% 53.87% 54.03%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.55 1.31 1.47 1.36 1.49 1.43 1.36 1.30 1.27 1.33 1.35
Quick Ratio
0.88 0.70 0.74 0.68 0.74 0.79 0.77 0.70 0.67 0.71 0.74
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-6,567 -3,755 -403 -286 -40 124 555 123 395 120 -34
Operating Cash Flow to CapEx
-154.76% 92.00% 137.93% 0.00% -205.56% 245.95% 455.81% 133.33% -139.47% -200.00% 333.33%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.67 0.54 0.41 0.42 0.40 0.41 0.40 0.40 0.00 0.00 0.43
Accounts Receivable Turnover
0.00 0.00 498.92 464.31 426.86 390.67 412.86 405.93 0.00 0.00 362.06
Inventory Turnover
0.00 3.59 2.65 2.90 2.65 2.78 2.72 2.84 0.00 0.00 3.06
Fixed Asset Turnover
1.59 1.60 1.22 1.24 1.18 1.16 1.14 1.14 0.00 0.00 1.27
Accounts Payable Turnover
0.00 0.00 3.51 3.47 3.45 3.55 3.49 3.23 0.00 0.00 3.44
Days Sales Outstanding (DSO)
0.00 0.00 0.73 0.79 0.86 0.93 0.88 0.90 0.00 0.00 1.01
Days Inventory Outstanding (DIO)
0.00 101.75 137.66 125.95 137.57 131.34 134.19 128.40 0.00 0.00 119.31
Days Payable Outstanding (DPO)
0.00 0.00 104.01 105.09 105.93 102.89 104.50 113.08 0.00 0.00 106.22
Cash Conversion Cycle (CCC)
0.00 101.75 34.39 21.65 32.50 29.38 30.57 16.22 0.00 0.00 14.10
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
8,891 9,011 9,038 8,631 8,950 8,803 8,487 8,467 8,544 8,696 8,518
Invested Capital Turnover
1.06 0.84 0.68 0.71 0.67 0.66 0.66 0.66 0.00 0.00 0.72
Increase / (Decrease) in Invested Capital
6,540 3,779 397 242 59 -208 -551 -164 -406 -107 31
Enterprise Value (EV)
7,068 6,713 6,989 5,825 5,777 4,950 4,508 4,676 5,494 5,170 4,665
Market Capitalization
4,490 3,939 4,187 3,119 2,731 1,810 1,560 1,716 2,316 1,862 1,473
Book Value per Share
$18.40 $18.05 $18.06 $17.15 $17.07 $16.32 $15.96 $15.87 $15.43 $15.38 $15.19
Tangible Book Value per Share
$6.55 $6.42 $6.49 $5.85 $5.84 $5.28 $5.08 $5.07 $4.79 $5.03 $4.96
Total Capital
10,909 10,521 10,420 10,003 10,252 10,199 10,025 9,943 9,920 10,036 9,904
Total Debt
4,112 3,840 3,718 3,670 3,908 4,070 4,016 4,022 4,112 4,174 4,086
Total Long-Term Debt
3,320 2,688 3,026 3,020 3,340 3,326 3,260 3,316 3,360 3,446 3,480
Net Debt
2,094 2,330 2,336 2,298 2,606 2,674 2,478 2,546 2,736 2,834 2,700
Capital Expenditures (CapEx)
42 50 174 -82 36 37 43 57 38 30 33
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,426 1,542 1,508 1,095 1,397 1,277 985 801 937 1,157 1,049
Debt-free Net Working Capital (DFNWC)
2,530 2,212 2,168 1,775 2,065 2,075 1,921 1,659 1,675 1,849 1,767
Net Working Capital (NWC)
1,738 1,060 1,476 1,125 1,497 1,331 1,165 953 923 1,121 1,161
Net Nonoperating Expense (NNE)
-3.60 -14 11 81 7.67 61 15 41 30 5.81 2.00
Net Nonoperating Obligations (NNO)
2,094 2,330 2,336 2,298 2,606 2,674 2,478 2,546 2,736 2,834 2,700
Total Depreciation and Amortization (D&A)
69 75 284 -139 69 72 73 73 73 77 77
Debt-free, Cash-free Net Working Capital to Revenue
23.87% 25.90% 25.19% 18.14% 23.38% 21.79% 17.04% 14.09% 0.00% 0.00% 17.04%
Debt-free Net Working Capital to Revenue
42.34% 37.16% 36.21% 29.41% 34.55% 35.41% 33.24% 29.19% 0.00% 0.00% 28.71%
Net Working Capital to Revenue
29.09% 17.81% 24.65% 18.64% 25.05% 22.71% 20.16% 16.77% 0.00% 0.00% 18.86%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.22) $0.13 ($0.19) ($0.82) ($0.03) ($0.92) ($0.14) ($0.56) ($0.31) ($0.03) ($0.10)
Adjusted Weighted Average Basic Shares Outstanding
171.80M 172.10M 172.10M 172.10M 172.40M 172.60M 172.60M 172.60M 173M 173.40M 173.40M
Adjusted Diluted Earnings per Share
($0.22) $0.13 ($0.19) ($0.82) ($0.03) ($0.92) ($0.14) ($0.56) ($0.31) ($0.03) ($0.10)
Adjusted Weighted Average Diluted Shares Outstanding
171.80M 172.80M 172.10M 172.10M 172.40M 172.60M 172.60M 172.60M 173M 173.40M 173.40M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
173.00M 173.00M 172.99M 172.98M 173.75M 173.75M 173.75M 174.01M 175.35M 175.38M 175.33M
Normalized Net Operating Profit after Tax (NOPAT)
-19 27 33 -44 7.00 2.80 13 -41 -7.00 32 30
Normalized NOPAT Margin
-1.29% 1.70% 2.14% -3.04% 0.50% 0.19% 0.86% -3.05% -0.49% 1.94% 1.75%
Pre Tax Income Margin
-2.45% 2.80% 2.21% -5.58% 1.91% -9.53% -0.48% -5.39% -2.04% 1.56% 1.51%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-677.78% -1,113.79% -227.87% -204.72% -279.57% -81.16% -68.89% -89.87% 0.00% 0.00% -93.39%
Augmented Payout Ratio
-1,383.33% -1,655.17% -332.79% -211.81% -288.17% -84.06% -72.96% -91.19% 0.00% 0.00% -95.87%

Financials Breakdown Chart

Key Financial Trends

Huntsman’s Q2 2026 results show a meaningful sequential improvement in profitability, but the company’s broader financial trend remains mixed. Revenue increased to $1.663 billion from $1.420 billion in Q1 2026 and $1.458 billion in Q2 2025. Gross profit rose to $245 million, producing a 14.7% gross margin versus 12.9% in Q1. Operating income also improved from a $16 million loss in Q1 to $37 million of income in Q2.

Despite the operating recovery, Huntsman generated only $9 million of net income from continuing operations and a $6 million net loss attributable to common shareholders, or negative $0.03 per share. Interest and other expenses reduced pretax income by $11 million, while $13 million of earnings was attributed to noncontrolling interests. The company also reported a $2 million loss from discontinued operations.

The longer-term revenue trend is less encouraging. Quarterly revenue has generally declined from $2.011 billion in Q3 2022 to $1.506 billion in Q3 2023, $1.452 billion in Q4 2024, and $1.355 billion in Q4 2025, before recovering in the first half of 2026. Profitability has also deteriorated from the 2022 level, when Huntsman produced a 17.4% gross margin and $138 million of operating income in Q3, compared with a 14.7% gross margin and $37 million of operating income in Q2 2026.

Cash flow is the most significant near-term concern. Huntsman used $60 million in operating cash during Q2 2026, following a $53 million outflow in Q1. The primary driver was a $165 million use of cash from changes in operating assets and liabilities, suggesting that working capital absorbed substantial funds. This compares with positive operating cash flow of $91 million in Q2 2025 and $46 million in Q2 2024.

The balance sheet provides some liquidity, but cash has declined. Cash and equivalents stood at $692 million at the end of Q2 2026, down from $738 million in Q1 2026 and $798 million in Q2 2025. Total debt was approximately $4.17 billion, consisting of $728 million of short-term debt and $3.446 billion of long-term debt. The current ratio was approximately 1.33, indicating coverage of current liabilities but limited excess liquidity for a cyclical chemical manufacturer.

  • Sequential earnings recovery: Q2 2026 operating income improved to $37 million from a $16 million loss in Q1 2026, while net income from continuing operations rose to $9 million from a $40 million loss.
  • Revenue rebound: Q2 2026 revenue increased approximately 17% sequentially and 14% year over year, reversing part of the weakness seen through 2025.
  • Improved gross profitability: Gross margin expanded to about 14.7% in Q2 2026 from 12.9% in Q1 and 12.5% in Q2 2025.
  • Lower restructuring burden: Restructuring charges fell to $9 million in Q2 2026 from $124 million in Q2 2025, helping operating income return to positive territory.
  • Capital investment remains active: Huntsman spent $30 million on property, plant and equipment in Q2 2026, below the $38 million spent in Q1 and $37 million in Q2 2025. This may support future operations, although it continues to consume cash.
  • Liquidity remains adequate but weakening: The company had $692 million of cash and a current ratio near 1.33 at quarter-end, but cash has declined from $798 million a year earlier and $1.104 billion in Q1 2024.
  • Operating cash flow turned sharply negative: Huntsman used $60 million in operating cash in Q2 2026, primarily because operating assets and liabilities consumed $165 million.
  • Common shareholders remain unprofitable: Q2 2026 net income attributable to common shareholders was negative $6 million, producing negative EPS of $0.03 despite positive consolidated net income.
  • Revenue and margins remain below earlier-cycle levels: Revenue and gross margins are still well below Q3 2022 levels, indicating that the latest improvement may represent a recovery from depressed conditions rather than a return to prior peak performance.
  • Debt and financing dependence remain important risks: Total debt rose to approximately $4.17 billion, while Q2 financing included $36 million of new debt issuance. Huntsman also paid $44 million in dividends despite negative operating cash flow.

Overall, Huntsman’s latest quarter suggests that operating conditions may be stabilizing, particularly as restructuring costs decline and revenue improves. However, negative operating cash flow, declining cash reserves, substantial debt, and continued losses for common shareholders remain important risks. Investors should look for sustained positive operating cash flow and several quarters of improved margins before treating the Q2 rebound as a durable turnaround.

11/18/26 03:04 PM ETAI Generated. May Contain Errors.

Huntsman Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Huntsman's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Huntsman's net income appears to be on a downward trend, with a most recent value of -$227 million in 2025, compared with $126 million in 2015. The previous period was -$127 million in 2024. Check out Huntsman's forecast to explore projected trends and price targets.

Huntsman's total operating income in 2025 was -$131 million, based on the following breakdown:
  • Total Gross Profit: $751 million
  • Total Operating Expenses: $882 million

Over the last 10 years, Huntsman's total revenue changed from $8.14 billion in 2015 to $5.68 billion in 2025, a change of -30.2%.

In the past 13 quarters, Huntsman's cash and equivalents has ranged from $502 million in Q2 2023 to $1.10 billion in Q1 2024, and is currently $718 million as of their latest financial filing in Q3 2026.

Huntsman had total debt of $4.02 billion at the end of 2025, a 9.6% increase from 2024, and a 16.1% decrease since 2015.

Over the last 10 years, Huntsman's book value per share changed from 5.88 in 2015 to 15.87 in 2025, a change of 170.1%.



Financial statements for NYSE:HUN last updated on 11/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners